Why is Trastuzumab Injection recommended for Breast Cancer Patients?

Breast cancer continues to be a major health issue for women all around the world. With the progress that science has made in the medical field, it has become possible to treat diseases in a more effective manner. One such example is that of Trastuzumab, which is used specifically to treat HER2 positive breast cancer patients.

What is HER2-Positive Breast Cancer?

Her2-positive breast cancer is one type that has an abnormal amount of HER2 proteins in their cancerous cells. The HER2 proteins promote the growth and proliferation of the cancerous cells; therefore, this type is much more aggressive compared to other types of breast cancer. However, this protein enables doctors to target cancer cells using targeted therapies.

What Is The Role of Injection ?

The Trastuzumab 440mg Injection in Breast Cancer is a type of monoclonal antibody that specifically targets HER2 receptors. It is typically delivered by intravenous (IV) infusion. Patient can either take it alone or with other medications such as chemotherapy for increased effectiveness.

How Does The Medicine Work In Breast Cancer?

The Injection acts by attaching itself to the HER2 receptors located on the surface of the cells which have become cancerous. This attachment prevents any communication between the cells that leads to their rapid division and hence the formation of the tumors. Apart from this, It also helps in the activation of the immune system of the body to help fight against cancer.

When is The Injection Prescribed To The Patient?

Medicine is administered under certain conditions where there is an overexpression of HER2 protein in cancerous cells and is selected according to the stages and objectives of cancer treatment:

• For early stages of HER2-positive breast cancer for controlling tumor growth and enhancing treatment efficacy when combined with chemotherapy.

• Post-surgery for eliminating the existing cancerous cells and preventing future recurrence of cancer.

• Advanced or metastatic breast cancer to slow down the progression of disease and increase the survival rate.

Conclusion

Advancements in targeted therapy have revolutionized treatment for breast cancer. Trastuzumab Injection, a targeted therapy that focus on cancerous cells that exhibit positive HER2, providing a better and tailored solution for such cases. With appropriate medical oversight, the medicine remains an important treatment for treating breast cancer.

FAQs

1. What are the tests that need to be done before beginning the therapy?

Before beginning with the treatment, patients need to have a HER2 test done. Sometimes doctors will perform other tests such as echocardiograms to evaluate cardiac functions both before and during the therapy.

2. How does patient administer The Injection?

The medicine needs to be administered through an IV infusion at hospital or clinical setting under doctor guidance.